Lateral pelvic lymph node dissection (LPLND) is a surgical procedure that plays a crucial role in the treatment of rectal cancer, particularly for patients with metastatic lateral lymph nodes.
Researchers have introduced an innovative surgical technique for treating bladder cancer that could revolutionize the field of urological oncology.
You might have surgery to remove lymph nodes in your tummy (abdomen). These are called the retroperitoneal lymph nodes. This operation is called a retroperitoneal lymph node dissection ... The surgeon ...
Prospective nonrandomized evidence demonstrated a survival benefit for extended pelvic lymph node dissection. Improvement on staging has also been suggested by the presence of skip metastatic ...
Robotic cystectomy is associated with less blood loss than open surgery. The extent of pelvic lymph node dissection is comparable between robotic and open surgery. Length of stay may be improved ...
underwent a successful nerve sparing robotic radical prostatectomy with amniotic nerve wrap with bilateral pelvic lymph node dissection. A 61-year-old female patient successfully underwent a ...
No significant differences were found in lymph node dissection (LND), postoperative hospital stay ... Although the third-generation da Vinci robotic system was introduced at our center in 2019 to ...
The robotic approach offers enhanced precision and visualization ... preoperative imaging evaluation did not show any lymph node metastasis, so pelvic lymph node dissection was not performed. TUR is ...
who published a series of 442 patients who underwent a radical cystectomy plus pelvic lymph node dissection, with or without chemotherapy ... Sayyid, MD, MSc – Robotic Urologic Oncology Fellow at The ...
Patients with stage 3 colon cancer are initially treated with surgery to remove the cancer in the colon and nearby lymph nodes. After this treatment, they typically receive adjuvant chemotherapy ...
Association between adjuvant component of perioperative chemotherapy and survival outcomes in resected gastric cancer (GC).